![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Chembio Nabs CE Mark for Multiplex Diagnostic
Chembio Nabs CE Mark for Multiplex Diagnostic
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Chembio_Logo.gif?t=1576721381&width=430)
Chembio Diagnostics has earned the CE Mark for its point-of-care Dual Path Platform (DPP) multiplex test for the Zika, dengue and chikungunya viruses.
The diagnostic provides simultaneous detection of the antibodies for active and prior exposure to the viruses — an important distinction for treatment.
The test uses a small drop of blood from the fingertip and works in conjunction with the company’s DPP Micro Reader device to provide results in approximately 15 minutes.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct